| # | Drug | Count |
|---|---|---|
| 0 | GEMCITABINE | 15 |
| 1 | GEMCITABINE HYDROCHLORIDE | 15 |
| 2 | CISPLATIN | 10 |
| 3 | DOXORUBICIN | 10 |
| 4 | CARBOPLATIN | 5 |
| 5 | PACLITAXEL | 5 |
| 6 | PACLITAXEL (AIBUMIN-BOUND) | 5 |
| 7 | METHOTREXATE | 4 |
| 8 | METHOTREXATE SODIUM | 4 |
| 9 | BEVACIZUMAB | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOPOTECAN HYDROCHLORIDE | 1 | 0.0004 |
| 1 | GEMCITABINE HYDROCHLORIDE | 15 | 0.0003 |
| 2 | PEGFILGRASTIM | 2 | 0.0002 |
| 3 | TOPOTECAN | 1 | 0.0002 |
| 4 | ERLOTINIB HYDROCHLORIDE | 2 | 0.0002 |
| 5 | ZOLMITRIPTAN | 1 | 0.0001 |
| 6 | CISPLATIN | 10 | 0.0001 |
| 7 | EVEROLIMUS TABLETS | 2 | 0.0001 |
| 8 | DOXORUBICIN | 10 | 0.0001 |
| 9 | IFOSFAMIDE FOR INJECTION | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Platinum-based Drug [EPC] | 12 | 0.0000 |
| 1 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 1 | 0.0000 |
| 2 | Microtubule Inhibitor [EPC] | 5 | 0.0000 |
| 3 | Leukocyte Growth Factor [EPC] | 4 | 0.0000 |
| 4 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 5 | Proteasome Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 3 | 0.0000 |
| 7 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Alkylating Drug [EPC] | 3 | 0.0000 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 4 | 0.0000 |